Benjamin Looker insider trades

Open-market stock purchases and sales by Benjamin Looker, Chief Legal Officer at Esperion Therapeutics, Inc, from SEC Form 4 filings since May 3, 2021.

Recent trades

DateStockTradeValue
Jun 17, 2026ESPR Esperion Therapeutics, IncSold$37.3K
Mar 17, 2026ESPR Esperion Therapeutics, IncSold$15.4K
Mar 13, 2026ESPR Esperion Therapeutics, IncBought (not open market)—
Mar 13, 2026ESPR Esperion Therapeutics, IncBought (not open market)—
Jan 20, 2026ESPR Esperion Therapeutics, IncSold$4.9K
Dec 17, 2025ESPR Esperion Therapeutics, IncSold$23.9K
Oct 17, 2025ESPR Esperion Therapeutics, IncSold$3.3K

Companies traded

  • ESPR Esperion Therapeutics, Inc: 10 sales, last Jun 17, 2026
  • TRIL Trillium Therapeutics Inc: other filings, last Nov 17, 2021

Get free alerts when Benjamin Looker files a new trade →